Review




Structured Review

BioNTech pfizer astrazeneca
Pfizer Astrazeneca, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc11044684-18-7-7?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer astrazeneca - by Bioz Stars, 2026-06
90/100 stars

Images



Similar Products

86
Pfizer Inc compound roche iconix rs 504393 millennium pfizer benzimidazoles smithkline sb 380732 astrazeneca azd 6942 merck teijin bms 3
Compound Roche Iconix Rs 504393 Millennium Pfizer Benzimidazoles Smithkline Sb 380732 Astrazeneca Azd 6942 Merck Teijin Bms 3, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/us12514937-229-1-5?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
compound roche iconix rs 504393 millennium pfizer benzimidazoles smithkline sb 380732 astrazeneca azd 6942 merck teijin bms 3 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Merck & Co compound roche iconix rs 504393 millennium pfizer benzimidazoles smithkline sb 380732 astrazeneca azd 6942 merck teijin bms 3
Compound Roche Iconix Rs 504393 Millennium Pfizer Benzimidazoles Smithkline Sb 380732 Astrazeneca Azd 6942 Merck Teijin Bms 3, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/us12514937-229-1-11?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
compound roche iconix rs 504393 millennium pfizer benzimidazoles smithkline sb 380732 astrazeneca azd 6942 merck teijin bms 3 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

86
Pfizer Inc la estrategia de vacunación que combina una vacuna de rnam como pfizer y una vacuna vectorizada con adenovirus como astrazeneca
La Estrategia De Vacunación Que Combina Una Vacuna De Rnam Como Pfizer Y Una Vacuna Vectorizada Con Adenovirus Como Astrazeneca, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc12879979-271-5-16?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
la estrategia de vacunación que combina una vacuna de rnam como pfizer y una vacuna vectorizada con adenovirus como astrazeneca - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
AstraZeneca ltd astrazeneca/pfizer
Median delay between last vaccine dose or infection and sample collection for groups 1 to 4.
Astrazeneca/Pfizer, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc11141348-37-0-1?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
astrazeneca/pfizer - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
BioNTech pfizer astrazeneca
Median delay between last vaccine dose or infection and sample collection for groups 1 to 4.
Pfizer Astrazeneca, supplied by BioNTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc11044684-18-7-7?v=BioNTech
Average 90 stars, based on 1 article reviews
pfizer astrazeneca - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd astrazeneca/pfizer-biontech
Demographic and anamnestic information of the subjects who received a nasopharyngeal swab at the drive-through center.
Astrazeneca/Pfizer Biontech, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc10209336-36-0-1?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
astrazeneca/pfizer-biontech - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Moderna vaccines pfizer, oxford astrazeneca, against covid-19 virus
Results of mediation analyses for study 1, with perception of the lack of government transparency as a predictor, conspiracy mentality as mediator and beliefs in <t>COVID-19</t> conspiracies as depended variable.
Vaccines Pfizer, Oxford Astrazeneca, Against Covid 19 Virus, supplied by Moderna, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/pmc10009001-43-145-142?v=Moderna
Average 90 stars, based on 1 article reviews
vaccines pfizer, oxford astrazeneca, against covid-19 virus - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd pfizer/astrazeneca
Results of mediation analyses for study 1, with perception of the lack of government transparency as a predictor, conspiracy mentality as mediator and beliefs in <t>COVID-19</t> conspiracies as depended variable.
Pfizer/Astrazeneca, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pfizer+astrazeneca/10__5235_slash_17441056__10__3__453-186-134-135?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
pfizer/astrazeneca - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Median delay between last vaccine dose or infection and sample collection for groups 1 to 4.

Journal: Heliyon

Article Title: Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada

doi: 10.1016/j.heliyon.2024.e31026

Figure Lengend Snippet: Median delay between last vaccine dose or infection and sample collection for groups 1 to 4.

Article Snippet: Mix AstraZeneca/Pfizer or Moderna , – , , – , , 49 , (24).

Techniques: Infection

Comparison of live neutralizing antibody titers in participants after homologous or heterologous vaccination, infection followed by vaccination or vice-versa. Food and retail workers received two or three doses of mRNA vaccines (Pfizer, Moderna or AstraZeneca) or a combination of them. (A) Serum neutralizing antibody of all participants against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains. Each circle represents a single participant. Bars identify mean NtAbs titers of the group with 95 % confidence intervals (CI). The horizontal dashed line indicates the limit of detection for the neutralization assay (neutralizing titer of 10). The samples that did not neutralize SARS-CoV-2 at 1:20 serum dilution was given a neutralizing titer of 10 for graphic representation and statistical analysis. The fold-change of the mean NtAbs titer and significant p-value ( p ≤ 0.05) are denoted on the line. Significance was assessed using GEE linear regression mixed model with Tukey-Kramer adjusted p-values. (B) Serum neutralizing antibody of participants from grocery stores (105), restaurants/bar (133) and hardware stores (42) against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains. Significance was assessed with Kruskal-Wallis one-way ANOVA followed by Dunn's multiple comparison test.

Journal: Heliyon

Article Title: Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada

doi: 10.1016/j.heliyon.2024.e31026

Figure Lengend Snippet: Comparison of live neutralizing antibody titers in participants after homologous or heterologous vaccination, infection followed by vaccination or vice-versa. Food and retail workers received two or three doses of mRNA vaccines (Pfizer, Moderna or AstraZeneca) or a combination of them. (A) Serum neutralizing antibody of all participants against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains. Each circle represents a single participant. Bars identify mean NtAbs titers of the group with 95 % confidence intervals (CI). The horizontal dashed line indicates the limit of detection for the neutralization assay (neutralizing titer of 10). The samples that did not neutralize SARS-CoV-2 at 1:20 serum dilution was given a neutralizing titer of 10 for graphic representation and statistical analysis. The fold-change of the mean NtAbs titer and significant p-value ( p ≤ 0.05) are denoted on the line. Significance was assessed using GEE linear regression mixed model with Tukey-Kramer adjusted p-values. (B) Serum neutralizing antibody of participants from grocery stores (105), restaurants/bar (133) and hardware stores (42) against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains. Significance was assessed with Kruskal-Wallis one-way ANOVA followed by Dunn's multiple comparison test.

Article Snippet: Mix AstraZeneca/Pfizer or Moderna , – , , – , , 49 , (24).

Techniques: Comparison, Infection, Vaccines, Neutralization

Neutralizing antibody titers against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains in all volunteers regarding the number of vaccine doses received and if they were infected before or after vaccinations. (A) Group 1 (n = 16); infected, Pfizer (n = 11), Moderna (n = 3), Pfizer/Moderna (n = 1) or AstraZeneca (n = 1)); Groupe 2 (n = 144); 2 doses of Pfizer (n = 85), Pfizer/Moderna or vice versa (n = 2), Moderna/Moderna (n = 41) and AstraZeneca and Pfizer or Moderna (n = 16); Group 3 (n = 84); 3 doses of Pfizer (n = 17), 3 doses of Moderna (n = 16), Moderna/Moderna/Pfizer (n = 5), Pfizer/Pfizer/Moderna (n = 19), Pfizer/Moderna/Pfizer or Moderna (n = 3), AstraZeneca/AstraZeneca/Pfizer or Moderna (n = 4) or AstraZeneca/Pfizer or Moderna/Moderna (n = 20); Group 4 (n = 36): participants received at least 2 doses of vaccine (Pfizer/Pfizer (n = 25), Moderna/Moderna (n = 7), AstraZeneca/AstraZeneca or AstraZeneca/Moderna (n = 4)) and then were infected. (B) Neutralizing antibody titers for each participant against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains regarding type of vaccine regimen. Each circle represents a single participant. In the first group, the green and red points represent participants vaccinated with 1 and 3 doses and then infected, respectively. Bars identify mean NtAbs titers of the group with 95 % CI. The horizontal dashed line indicates the limit of detection for the neutralization assay (neutralizing titer of 10). The samples that did not neutralize SARS-CoV-2 at 1:20 serum dilution was given a neutralizing titer of 10 for graphic representation and statistical analysis. The fold-change of the mean NtAbs titer and significant p-value ( p ≤ 0.05) are denoted on the line. Significance was assessed with Kruskal-Wallis one-way ANOVA followed by Dunn's multiple comparison test.

Journal: Heliyon

Article Title: Live virus neutralizing antibodies against pre and post Omicron strains in food and retail workers in Québec, Canada

doi: 10.1016/j.heliyon.2024.e31026

Figure Lengend Snippet: Neutralizing antibody titers against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains in all volunteers regarding the number of vaccine doses received and if they were infected before or after vaccinations. (A) Group 1 (n = 16); infected, Pfizer (n = 11), Moderna (n = 3), Pfizer/Moderna (n = 1) or AstraZeneca (n = 1)); Groupe 2 (n = 144); 2 doses of Pfizer (n = 85), Pfizer/Moderna or vice versa (n = 2), Moderna/Moderna (n = 41) and AstraZeneca and Pfizer or Moderna (n = 16); Group 3 (n = 84); 3 doses of Pfizer (n = 17), 3 doses of Moderna (n = 16), Moderna/Moderna/Pfizer (n = 5), Pfizer/Pfizer/Moderna (n = 19), Pfizer/Moderna/Pfizer or Moderna (n = 3), AstraZeneca/AstraZeneca/Pfizer or Moderna (n = 4) or AstraZeneca/Pfizer or Moderna/Moderna (n = 20); Group 4 (n = 36): participants received at least 2 doses of vaccine (Pfizer/Pfizer (n = 25), Moderna/Moderna (n = 7), AstraZeneca/AstraZeneca or AstraZeneca/Moderna (n = 4)) and then were infected. (B) Neutralizing antibody titers for each participant against ancestral SARS-CoV-2, Delta, BA.1, BA.2, BA.2.12.1, BA.4 and BA.5 strains regarding type of vaccine regimen. Each circle represents a single participant. In the first group, the green and red points represent participants vaccinated with 1 and 3 doses and then infected, respectively. Bars identify mean NtAbs titers of the group with 95 % CI. The horizontal dashed line indicates the limit of detection for the neutralization assay (neutralizing titer of 10). The samples that did not neutralize SARS-CoV-2 at 1:20 serum dilution was given a neutralizing titer of 10 for graphic representation and statistical analysis. The fold-change of the mean NtAbs titer and significant p-value ( p ≤ 0.05) are denoted on the line. Significance was assessed with Kruskal-Wallis one-way ANOVA followed by Dunn's multiple comparison test.

Article Snippet: Mix AstraZeneca/Pfizer or Moderna , – , , – , , 49 , (24).

Techniques: Infection, Neutralization, Comparison

Demographic and anamnestic information of the subjects who received a nasopharyngeal swab at the drive-through center.

Journal: Heliyon

Article Title: Sensitivity and specificity of in vivo COVID-19 screening by detection dogs: Results of the C19-Screendog multicenter study

doi: 10.1016/j.heliyon.2023.e15640

Figure Lengend Snippet: Demographic and anamnestic information of the subjects who received a nasopharyngeal swab at the drive-through center.

Article Snippet: Heterologous AstraZeneca/ Pfizer-BioNTech , , 11 , – , .

Techniques:

Results of mediation analyses for study 1, with perception of the lack of government transparency as a predictor, conspiracy mentality as mediator and beliefs in COVID-19 conspiracies as depended variable.

Journal: Psychological Reports

Article Title: Perceived Government Transparency and COVID-19 Conspiracy Beliefs: The Mediating Role of Conspiracy Mentality

doi: 10.1177/00332941231161789

Figure Lengend Snippet: Results of mediation analyses for study 1, with perception of the lack of government transparency as a predictor, conspiracy mentality as mediator and beliefs in COVID-19 conspiracies as depended variable.

Article Snippet: We ask to what degree participants agree with the various theories related to the origin of COVID-19 and to vaccines for COVID-19 (eight items as follows: ‘The virus originated in American laboratories and was used as a biological weapon against China’; ‘The virus originated in Chinese laboratories as a bioweapon, but was accidentally found outside the lab’; ‘The virus originated as a bioweapon, we don’t know by whom it was developed, and is being spread by cell phone masts (5G transmitters)’; ‘The virus was created by an accidental mutation in the body of some animal and jumped to humans’ (reversed coded); ‘The COVID-19 virus is definitely less harmful than presented by mainstream media’; ‘The virus was created so that certain groups of corporations and wealthy people could profit from the economic shock caused by the pandemic’; ‘The vaccines from Pfizer, Oxford AstraZeneca, Moderna against the COVID-19 virus can do more damage to the body than the coronavirus itself’; ‘Vaccines from Pfizer, Oxford AstraZeneca, Moderna against the COVID-19 virus are mostly safe and protect those vaccinated’ (reversed coded)).

Techniques:

Results of mediation analyses for study 2, with perception of the lack of government transparency as a predictor (dummy coded, priming lack of transparency = 1, control group = 0), conspiracy mentality as mediator and beliefs in COVID-19 conspiracies as depended variable.

Journal: Psychological Reports

Article Title: Perceived Government Transparency and COVID-19 Conspiracy Beliefs: The Mediating Role of Conspiracy Mentality

doi: 10.1177/00332941231161789

Figure Lengend Snippet: Results of mediation analyses for study 2, with perception of the lack of government transparency as a predictor (dummy coded, priming lack of transparency = 1, control group = 0), conspiracy mentality as mediator and beliefs in COVID-19 conspiracies as depended variable.

Article Snippet: We ask to what degree participants agree with the various theories related to the origin of COVID-19 and to vaccines for COVID-19 (eight items as follows: ‘The virus originated in American laboratories and was used as a biological weapon against China’; ‘The virus originated in Chinese laboratories as a bioweapon, but was accidentally found outside the lab’; ‘The virus originated as a bioweapon, we don’t know by whom it was developed, and is being spread by cell phone masts (5G transmitters)’; ‘The virus was created by an accidental mutation in the body of some animal and jumped to humans’ (reversed coded); ‘The COVID-19 virus is definitely less harmful than presented by mainstream media’; ‘The virus was created so that certain groups of corporations and wealthy people could profit from the economic shock caused by the pandemic’; ‘The vaccines from Pfizer, Oxford AstraZeneca, Moderna against the COVID-19 virus can do more damage to the body than the coronavirus itself’; ‘Vaccines from Pfizer, Oxford AstraZeneca, Moderna against the COVID-19 virus are mostly safe and protect those vaccinated’ (reversed coded)).

Techniques: